Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Cleveland BioLabs logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$4.34
52-Week Range
N/A
Volume
823 shs
Average Volume
271,922 shs
Market Capitalization
$5,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cytocom, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.

Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

CBLI Stock News Headlines

Cleveland Construction News
Breaking News: Tesla headed to $500…
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
See More Headlines

CBLI Stock Analysis - Frequently Asked Questions

Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced its earnings results on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share for the quarter. The biotechnology company had revenue of $0.16 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cleveland BioLabs investors own include iBio (IBIO), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Novavax (NVAX) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/15/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
Fax
N/A
Employees
4
Year Founded
2003

Profitability

Net Income
$-2,400,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$260,000.00
Book Value
$0.87 per share

Miscellaneous

Free Float
N/A
Market Cap
$5,000.00
Optionable
Not Optionable
Beta
0.70

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NASDAQ:CBLI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners